Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 148 entries
View as:

Biological Therapy in Treating Women With Stage IV Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00027807 Org: User:
Start: 10/31/01 End: 03/31/13 Due: 03/31/14

Chemotherapy and Bone Marrow Transplantation in Treating Patients Acute Myeloid With Leukemia or Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00002547 Org: User:
Start: 08/31/87 End: 10/31/03 Due: 10/31/04

A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions

Phase: N/A Priority: Normal
NCT ID: NCT07042191 Org: User:
Start: 12/09/22 End: 05/31/27 Due: 05/31/28

Melphalan and Palifermin in Treating Patients Undergoing An Autologous Peripheral Stem Cell Transplant for Stage II or III Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00482846 Org: User:
Start: 06/30/07 End: 09/30/12 Due: 09/30/13

Selinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03147885 Org: User:
Start: 06/20/17 End: 12/31/27 Due: 12/31/28

Tobacco Cessation Intervention

Phase: N/A Priority: Normal
NCT ID: NCT03657511 Org: User:
Start: 10/22/18 End: 06/21/21 Due: 06/21/22

LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02058706 Org: User:
Start: 05/31/14 End: 03/01/21 Due: 03/01/22

Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00003936 Org: User:
Start: 06/30/99 End: 06/30/04 Due: 06/30/05

Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00020722 Org: User:
Start: 08/31/07 End: 03/31/13 Due: 03/31/14

Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

Phase: N/A Priority: Normal
NCT ID: NCT00423826 Org: User:
Start: 01/31/07 End: 01/31/15 Due: 01/31/16

Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00258245 Org: User:
Start: 05/31/05 End: 04/30/08 Due: 04/30/09

Zoledronic Acid and Positron Emission Tomography in Treating Patients With Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00559897 Org: User:
Start: 03/31/08 End: 04/30/11 Due: 04/30/12

Biomarker 11-dh-TXB2 in Blood and Urine Samples From Patients With Prostate Cancer and Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00984919 Org: User:
Start: 11/30/09 End: 02/28/11 Due: 02/28/12

Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00942422 Org: User:
Start: 11/30/09 End: 03/31/12 Due: 03/31/13

Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent

Phase: N/A Priority: Normal
NCT ID: NCT02470559 Org: User:
Start: 06/30/15 End: 02/28/17 Due: 02/28/18

PET Scanning to Evaluate Zoledronate Efficacy in Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01205646 Org: User:
Start: 09/30/10 End: 08/31/15 Due: 08/31/16

Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00030420 Org: User:
Start: 10/31/01 End: 02/29/08 Due: 02/28/09

DISCO Application for the Improvement of Financial Outcomes in Patients With Hematologic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04282343 Org: User:
Start: 02/25/20 End: 10/21/22 Due: 10/21/23

First-line Pomalidomide, Bortezomib, and Dexamethasone For AL Amyloidosis or LCDD

Phase: N/A Priority: Normal
NCT ID: NCT01728259 Org: User:
Start: 03/31/13 End: 10/31/18 Due: 10/31/19

Dolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00003626 Org: User:
Start: 10/31/98 End: 05/31/00 Due: 05/31/01

Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01609816 Org: User:
Start: 02/12/15 End: 10/09/18 Due: 10/09/19

Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma

Phase: N/A Priority: Normal
NCT ID: NCT00004024 Org: User:
Start: 06/30/97 End: 01/31/04 Due: 01/31/05

Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00052403 Org: User:
Start: 02/28/02 End: - Due: -

Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel

Phase: N/A Priority: Normal
NCT ID: NCT00499694 Org: User:
Start: 10/31/07 End: 11/30/12 Due: 11/30/13

Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00376948 Org: User:
Start: 05/31/05 End: 03/31/10 Due: 03/31/11